Patents Assigned to Athanor Biosciences, Inc.
  • Bacteriophage-based vaccines and engineered bacteriophage
    Patent number: 11826421
    Abstract: Engineered bacteriophage and methods of forming the bacteriophage are described. Multivalent bacteriophage are described that can include multiple different exogenous polypeptides at a surface of the capsid head. Vaccines and methods of forming and using vaccines are described. A vaccine can include an engineered bacteriophage that exhibits an immunogenic exogenous polypeptide at a surface of the bacteriophage. Multivalent bacteriophage and immunogenic bacteriophage are free of nucleic acids encoding the exogenous polypeptide(s).
    Type: Grant
    Filed: March 18, 2021
    Date of Patent: November 28, 2023
    Assignee: Athanor Biosciences, Inc.
    Inventors: Hossein A Ghanbari, Michael S. Lebowitz